In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Intracardia Inc.

Division of Cardion AG

Latest From Intracardia Inc.

Selected Start-Ups (04/01)

In Vivo summarizes the technology of several recently founded companies: BioWisdom Ltd. is an Internet R&D portal to support site users through all phases of drug discovery and development. Cardion AG will focus on heart disease treatment and cell transplantation using its platforms in gene therapy and stem cell technology. EngeneOS Inc. platform combines biological and engineered components to create programmable biomolecular machines. FemtoLink Biotechnologies LLC aims to accelerate its clients' discovery efforts with its integrated platform for molecular diagnostics of proteins, metabolites and DNA. Labnetics Inc. will develop low cost, disposable diagnostics using miniaturized sensor beads encased in silicon wafers. SyneCor LLC is an accelerator for new cardiovascular device companies.

See All

Company Information

  • Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
  • Pharmaceuticals
  • Therapeutic Areas
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Cardion AG
  • Senior Management
  • Steve Gailar, CEO
  • Contact Info
  • Intracardia Inc.
    Cincinnati, OH